Richard G. Wunderink

Richard G. Wunderink

Top Cited Scholar 2023
Auto-generated profile, based on publicly available information

Richard G. Wunderink

Northwestern University Feinberg School of Medicine

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2007 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
LMLionel A. Mandell
Lionel A. Mandell
RWRichard G. Wunderink
Richard G. Wunderink
AAAntonio Anzueto
Antonio Anzueto
JBJohn G. Bartlett
John G. Bartlett
GCG. Douglas Campbell
G. Douglas Campbell
CWCynthia G. Whitney
Cynthia G. Whitney
Improving the care of adult patients with community-acquired pneumonia (CAP) has been the focus of many different organizations, and several have developed guid

30 July 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SJSeema Jain
Seema Jain
WSWesley H. Self
Wesley H. Self
RWRichard G. Wunderink
Richard G. Wunderink
SFSherene Fakhran
Sherene Fakhran
RBRobert Balk
Robert Balk
LFLyn Finelli
Lyn Finelli
Community-acquired pneumonia is a leading infectious cause of hospitalization and death among U.S. adults. Incidence estimates of pneumonia confirmed radiographically and with the use of current laboratory diagnostic tests are needed. We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among adults 18 years of age or older in five hospitals in Chicago and Nashville. Patients with recent hospitalization or severe immunosuppression were excluded. Blood, urine, and respiratory specimens were systematically collected for culture, serologic testing, antigen detection, and molecular diagnostic testing. Study radiologists independently reviewed chest radiographs. We calculated population-based incidence rates of community-acquired pneumonia requiring hospitalization according to age and pathogen. From January 2010 through June 2012, we enrolled 2488 of 3634 eligible adults (68%). Among 2320 adults with radiographic evidence of pneumonia (93%), the median age of the patients was 57 years (interquartile range, 46 to 71); 498 patients (21%) required intensive care, and 52 (2%) died. Among 2259 patients who had radiographic evidence of pneumonia and specimens available for both bacterial and viral testing, a pathogen was detected in 853 (38%): one or more viruses in 530 (23%), bacteria in 247 (11%), bacterial and viral pathogens in 59 (3%), and a fungal or mycobacterial pathogen in 17 (1%). The most common pathogens were human rhinovirus (in 9% of patients), influenza virus (in 6%), and Streptococcus pneumoniae (in 5%). The annual incidence of pneumonia was 24.8 cases (95% confidence interval, 23.5 to 26.1) per 10,000 adults, with the highest rates among adults 65 to 79 years of age (63.0 cases per 10,000 adults) and those 80 years of age or older (164.3 cases per 10,000 adults). For each pathogen, the incidence increased with age. The incidence of community-acquired pneumonia requiring hospitalization was highest among the oldest adults. Despite current diagnostic tests, no pathogen was detected in the majority of patients. Respiratory viruses were detected more frequently than bacteria. (Funded by the Influenza Division of the National Center for Immunizations and Respiratory Diseases.)

26 February 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SJSeema Jain
Seema Jain
DWDerek J. Williams
Derek J. Williams
SASandra R. Arnold
Sandra R. Arnold
KAKrow Ampofo
Krow Ampofo
ABAnna M. Bramley
Anna M. Bramley
LFLyn Finelli
Lyn Finelli
Incidence estimates of hospitalizations for community-acquired pneumonia among children in the United States that are based on prospective data collection are limited. Updated estimates of pneumonia that has been confirmed radiographically and with the use of current laboratory diagnostic tests are needed. We conducted active population-based surveillance for community-acquired pneumonia requiring hospitalization among children younger than 18 years of age in three hospitals in Memphis, Nashville, and Salt Lake City. We excluded children with recent hospitalization or severe immunosuppression. Blood and respiratory specimens were systematically collected for pathogen detection with the use of multiple methods. Chest radiographs were reviewed independently by study radiologists. From January 2010 through June 2012, we enrolled 2638 of 3803 eligible children (69%), 2358 of whom (89%) had radiographic evidence of pneumonia. The median age of the children was 2 years (interquartile range, 1 to 6); 497 of 2358 children (21%) required intensive care, and 3 (<1%) died. Among 2222 children with radiographic evidence of pneumonia and with specimens available for bacterial and viral testing, a viral or bacterial pathogen was detected in 1802 (81%), one or more viruses in 1472 (66%), bacteria in 175 (8%), and both bacterial and viral pathogens in 155 (7%). The annual incidence of pneumonia was 15.7 cases per 10,000 children (95% confidence interval [CI], 14.9 to 16.5), with the highest rate among children younger than 2 years of age (62.2 cases per 10,000 children; 95% CI, 57.6 to 67.1). Respiratory syncytial virus was more common among children younger than 5 years of age than among older children (37% vs. 8%), as were adenovirus (15% vs. 3%) and human metapneumovirus (15% vs. 8%). Mycoplasma pneumoniae was more common among children 5 years of age or older than among younger children (19% vs. 3%). The burden of hospitalization for children with community-acquired pneumonia was highest among the very young, with respiratory viruses the most commonly detected causes of pneumonia. (Funded by the Influenza Division of the National Center for Immunization and Respiratory Diseases.)

20 October 2017 in Respirology
Verified
Journal Article
Closed access
PDF file
YYYudong Yin
Yudong Yin
RWRichard G. Wunderink
Richard G. Wunderink

8 April 2021 in Nature Reviews Disease Primers
Verified
Journal Article
Closed access
PDF file
Antoni TorresAntoni Torres
Antoni Torres
Catia CillonizCatia Cilloniz
Catia Cilloniz
MNMichael S. Niederman
Michael S. Niederman
RMRosario Menéndez
Rosario Menéndez
JCJames D. Chalmers
James D. Chalmers
TPTom van der Poll
Tom van der Poll

11 January 2021 in Nature
Verified
Journal Article
Closed access
PDF file
RGRogan A. Grant
Rogan A. Grant
LMLuisa Morales-Nebreda
Luisa Morales-Nebreda
NMNikolay S. Markov
Nikolay S. Markov
SSSuchitra Swaminathan
Suchitra Swaminathan
MQMelissa Querrey
Melissa Querrey
RWRichard G. Wunderink
Richard G. Wunderink